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Interleukin (IL)-8 and gro peptides are members of the inter-
crine-a family of chemotaxins known to be present in bio-
logically a~tiv~ form in psoriasis l~sions. However, the rela-
tive contributIOn of the three dIfferent gro genes to 'the 
expression of this material is unknown, as is the stimulus for 
gro overexpression in psoriatic lesions . . T~ address these 
questions, ~orthern ?lot and semIquantItatIve polymerase 
chain reactIon analysIs were performed on RNA extracted 
from keratome biopsies of normal skin, untreated plaques of 
psoriasis, or plaques treated for 1 wee~ with low-d?se ~yclo­
sporin A (CsA). Northern blot analYSIS revealed a.sIgl1lfi~a~t 
correlation between gro and IL-8 mRNA levels m psonasls 
lesions from 26 different individuals (r = 0.61, P = 0.0009), 
and overexpression of gro was markedly reduced by CsA 
prior to detectable clinical improvement (79.3%, p = 0.01, 
n = 22). To determine which form(s) of gro were overex-
pressed in psoriatic lesions, total keratome RNA (1 ,ug) was 
I t has been suggested that several cytokines and growth fac-tors may play important roles in the pathogenesis of psoriasis [1- 3J. Interleukin (IL)-8 and melanoma growth-stimulatory activity (MGSA)/gro are heparin-binding polypeptides that display prominent neutrophil and/or lymphocyte chemo-
uctic properties [4 - 8J . Recently, three different gro genes have 
been identifled, which are tandemly repeated and clustered together 
with IL-8 and several related cytokines on human chromosomal 
band 4q21 [9). As a group, these genes have been called the inter-
crine-a subfami ly [10], which in addition to IL-8 and gro includes 
platelet factor 4, p-thromboglobulin, and IL-l 0 [11). The gro-a, -p, 
and -y genes are 85 - 90% homologous at the protein level, and share 
with IL-8 and the other intercrine-a family members a cysteine-X-
cysteine m.otif near the amino terminus of the mature polypeptide, 
leading to their deSignatIOn as the C-X-C protellls [12). In contrast, 
[he intercrine-p subfamily of genes, which are clustered on human 
chromosome 17, are characterized by a cysteine-cysteine motif ncar 
[he N terminus and have therefore been ca lled the C-C proteins 
[10 -12]. An important property of this family of cytokines is their 
inducibility by treatment with other, so-called "primary," cyto-
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analyze.d by se1:niquantitative reverse transcription-polymer-
ase cham reactIOn (SQRT-PCR). In five patients known to 
mar~edly overexpress gro and IL-8 rnRNAs by Northern 
blott111g, gro-a was approxim.ately six times more abundant 
than gro-p, and 25 times more abundant than gro-y. In cul-
tured .human keratinocytes, all three forms of gro mRNA 
were l1:creased by IL-la or by interferon (IFN)-y plus tumor 
necrOSIS factor (TNF)-a. However, in contrast to the situa-
tion in lIillO, CsA had no inhibitory effect on cytokine-stimu-
lated gro expression in cultured keratinocytes. Taken to-
gethe~, these results demonstrate that the gro-a gene is 
selectively overexpressed in fsoriatic lesions and strongly 
sugge~t that overex~ression 0 gro is a keratinocyte response 
to a~t1~ated T cells. m psoriasis. Key words: gro-a mRNA/ 
psonaSlS/cyclosponn A/melanoma growth-stimulatory ac-
tivity (MGSA) . ] Invest Dermatol1 01 :767 - 772, 1993 
kines, su~h as IL~ 1, tumor necrosis factor (TN F)-a, and interferon 
(IFN)-y, IdentlfYll1g them as important components of the cytokine 
cascade [10). 
Psoriatic scale was one of the earliest known sources of IL-8, 
initially called anionic neutrophil activating protein, or ANAP, by 
Schroder and colleagues [13). Recently, this group has reported the 
presence of approximately equal quantities of IL-8-related and 
MGSA/gro-reJa~ed p~oteins in psoriatic scale [14,15). These gro-
related polyp.epndes display potent neutrophil chemotactic activity f1 4J, su?gestmg that they may function along with IL-8 to attract 
~nfiltratlllg leukocytes to the epidermis in psoriasis, as well as other 
ll1f1ammatory der~atoses. However, the identity of the gro gene(s) 
that are expressed Ill. psoriatic lesions is unknown. Therefore, one 
major aim of these experiments was to determine which form(s) of 
gro mRNA are overexpressed in psoriatic lesions. 
Cyclo~porjn A (CsA) is an immunosuppressant drug thought to 
act selectively on the de novo activation ofT cells [16]. CsA has been 
con~rmed to be a highly effective treatment for psoriasis [17 -19J, 
and lts efficacy has been advanced as strong evidence for the im-
munopathogenesisof this disease [20J . One of the primary actions 
of CsA lS to 1l1lublt the production of T -cell - derived cytokines, 
such as IL-2 ~nd IFN-YJ21) . In turn, these cytokines could partici-
pate either dlrectly or 1l1dlrcctly in stimulating the expression of 
IL-8 and gro in nearby keratinocytes. Thus, IL-8 has been reported 
to be strongly ll1duced by IL-l or the combination of IFN-y and 
TNF-a in human keratinocytes [22,23J, and gro transcripts can be 
induced by IL-l and TNF in l~al111~ary-derived fibroblasts and epi-
thelial cells [9). C~nSlSt~nt With thiS hypothesis, we have recently 
reported that IL-8 IS vanably but coordinately overexpressed along 
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with IL-IP in psoriatic lesions, and that overexpression of both 
cytokines is rapidly reduced by CsA in psoriatic lesions, but not in 
cultured keratinocytes [24]. Therefore, to determine whether gro 
might display similar properties, the second aim of these experi-
ments was to determine whether gro and IL-8 are coordinately 
overexpressed in psoriasis lesions and reduced by CsA treatment ill 
vivo, but not in cultured keratinocytes. 
MATERIALS AND METHODS 
Patient Selection The 26 patients studied here were a subgroup of 85 
chronic psoriatics elUolled in the multidose CsA trial [18] . Twenty-two of 
these patients received CsA treatment at doses of3 mgjkgjd (nine patients), 
5 mg/kg/d (12 patients), or 7.5 mg/kg/d (one patient), or placebo consist-
ing of olive oil Labrafil base (four patients). For semiquanti tative reverse 
transcription-polymerase chain reaction (SQRT-PCR) analysis of gro-a, 
-p, and -y expression in psoriatic lesions, a subgroup of five of these patients 
was selected on the basis of high IL-8 and IL-1P expression [24]. Two of 
these eatients received CsA at a dose of 5 mg/kgj d and three at a dose of 
3 mg/kg/ d. Prior to and after 7 d of treatment, lesional buttocks or thigh 
skin was biopsied using a keratome as described [25]. Informed consent was 
obtained from each patient, and all studies involving human subjects were 
approved by the Institutional Review Board of the University of Michigan. 
Cell Culture Primary cultures of normal adult human keratinocytes were 
prepared as described [26] . Cells were treated for 16 h with CsA dissolved in 
dimethylsulfoxide (DMSO) vehicle (0.1 % final DMSO concentration), or 
with vehicle alone. The cells were then treated for an additional 6 h with 
IL-la (100 ngjml; Dainippon, Osaka, Japan) or a combination of IFN-y 
(100 U/ml, Collaborative Research, Bedford, MA) and TNF-a (20 ng/ml, 
Amgen, Thousand Oaks, CAl . After cytokine treatment, cultures were har-
vested for RNA isolation as described below. 
RNA Isolation and Blot Hybridization RNA was prepared from snap-
frozen keratome biopsies by the guanidinium isothionate-cesium chloride 
technique as previously described [25,26]. RNA was isolated from keratino-
cytes using RNAzol (Tel-Test, Friendswood, TX) as directed by the manu-
facturer. Forty micrograms total keratome RNA, or 20 /1g total keratinocyte 
RNA (determined by optical density [ODh6o) was resolved on 1% formal-
dehyde-agarose gels and blotted to Zeta-probe nylon membranes (Bio-Rad, 
Richmond, CAl. Blots were hybridized against 32P-labeled probes (see 
below). Quantitation of blots were performed either by laser densitometry of 
'autoradiograms [25] or by phosphorimager [27]. Gro hybridization signals 
were normalized to cyclophilin as previously described [25]' Blots were 
stripped for rehybridization by boiling twice for 20 min in 0.1 X saline 
sodium citrate/buffer (SSe), 0.5% sodium dodecyl sulfate. Statistical com-
parisons were made on the normalized data using analysis of variance. 
Plasmids and Hybridization Probes Plasmid DNAs were prepared by 
alkaline lysis and precipitation in polyethylene glycol (25). cDNA inserts 
werc prepared by digestion with appropriatc restriction cndonucleases fol-
lowed by electrophoresis in low - melting-temperature agarose gels. Inserts 
were 32P-labeled by random priming (1-4 X 109 cpm//1g DNA). The IL-8 
[24J, Iipocortin II [25J, 36B4 [28], and cyclophilin [25J probes used in these 
experiments have been previously described. Gro-a, -p, and -y hybridization 
probes were prepared from PCR products generated using primers similar to 
those described by Haskill et al [9]. The following primers were used: gro-a 
forward, 5'-GAA CTG CGC TGC CAG TG-3', gro-a reverse, 5'-GGC 
ATG TTG CAG GCT CCT CA-3'; gro-p forward, 5'-CTC AAG AAT 
GGG CGG AAA GCT -3', gro-p reverse 5' -CTC TGC TCT AAC ACA 
GAG GGA-3'; gro-y forward,S' -GAA CTG CGC TGC CAG TG-3' (same 
as used for gro-a); gro-y reverse 5'-AGG TGG CTG ACA CAT TAT 
GG-3'. For PCR, 1 jJ.g of totallesional psoriatic keratome RNA was con-
verted into first-strand cDNA using random hexamers or oligo(dT) primers 
as described by Kawasaki and Wang [29]. PCR amplification was then 
carried out on a 5-jJ.1 aliquot of cDNA following the same protocol. 
Semiquantitative PCR For cDNA synthesis, total keratome RNA 
(1 J.Lg), p-globin mRNA (1 pg, Gibco-BRL, Gaithersburg, MD), and oligo 
(dT) (1 /1g, Pharmacia, Piscataway, NJ) were mixed in a total volume of9 /11 
diethylpyrocarbonate (DEPe)-treated, autoclaved water. This reaction 
mixture was denatured for 10 min at 70°C, quench-cooled on ice, and 10 J.LI 
of 2 X RT-RXN buffer was added. 2 X RT-RXN buffer contained 4/11 
5 X H-RT buffer (Gibco-BRL), 2/11 5 mM dNTP mix, 2 J.L1 0.1 M dithio-
threitol (DTT), 0.5 J.LI RNasin (Promega, Madison, WI), and 1.5 Jll DEPC-
H20. After adding 1 J.Ll of Moloney murine leukemia virus (MMLV) reverse 
transcriptase (Gibco-BRL), the reaction was carried out at 37"C for 1 h, 
heated to 93°C for 5 min, and held on ice or stored at -20°C until use. 
Three fivefold serial dilutions of cDNA (i .e., 1: 5, 1 : 25, 1: 125) were 
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made in 1 X RT-RXN buffer and amplifie~ by PCR for 23-27 cycles as 
follows. Each reactIOn contal11ed 20/11 of dtluted cDNA solution, 6 .ul of 
10 X PCR buffer (Perkin Elmer-Cetus), 100 pmole each of forward and 
reve~se oligonucleotide primers, 0.2 J.LI (1 unit) Taq polymerase (Ampli Taq. 
Perkm Elmer-Cetus), and DEPC-H20 to a total volume of 80/11. Amp Wi: 
cation was for 1.5 mi~ at 94 o ~ (denaturation); 1.5 min at 50-60°C (primer 
annealmg), and 2.0 tnl11 at 72 C (pnmer extensIOn). After amplification th 
product of each reaction was subjected to electrophoresis through a 1'.5% 
agarose gel in 1 X TAE ~uffer as described [30) . The gels were blotted to 
Zeta-probe membrane (Blo-Rad, Rlch~nond, CAl under alkaline conditions 
as descnbed by the manufacturer, hybndlzed agamst the appropriate comb', 
nation op2P-labeled probes under stringent conditions [26], and quantitat~ 
by phosphorimager (27) . Size markers (123 ladder; Gibco-BRL) were visu, 
alized by addition of 1 X 10· cpm random-primed 123 ladder DNA to rh 
hybridization mix. For comparison of gro, IL-8, and cellular retinoic acid~ 
binding protein (CRABP)-II expression before and after CsA treatment 
specific hybridization signals were detected using the cognate PCR produ~ 
and normalized to p-globin as previously described [31]. For deterrninatio 
of relative abundance of gro-a, -p, and -y in the same RNA specimensl1 
normalization to p-globin was unnecessary and therefore omitted. In botl~ 
sets of experiments, a mixture of gro-a, -p, and -y probes was used fo 
hybridization. In preliminary experiments, each gro PCR product w~ 
shown to detect all three products with very similar sensitivity, and ve. 
similar results were obtained when the probes were used singly or in comb? 
nation (data not shown). 
The gro primer pair sequences used for semiquantitative PCR were iden_ 
tical to those used for probe isolation as described above. The IL-8, p-globin 
and CRABP-II primers were as follows: IL-8 forward, 5'-ATG ACT TCe 
AAG CTG GCC GTG-3'; IL-8 reverse, 5'-TTA TGA ATT CTC AGe 
CCT CTT CAA AAA CTT CTC-3'; p-globin forward, 5'-AAG GC1' 
CAT GGC AAG AAG GTG-3'; p-globin reverse, 5'-CTG CAC CTc 
AGG AGT GAA TTC-3'; CRABP-II forward, 5'-TAC ATC AAA ACe 
TCC ACC ACC GTG CGC ACC-3'; CRABP-II reverse, 5'-CGT CA1' 
GGT CAG GAT CAG TTC CCC ATC GTT-3'. 
RESULTS 
Clinical Evaluation As reported previously [18,24], there Was 
no significant difference in the Psoriasis Area and Severity Index 
(PAS I) score after 1 week of CsA therapy in either the entire group 
of CsA-treated patients or in the cohort of treated patients used for 
this study. However, with prolonged therapy, marked and signifi-
cant clinical improvement w as observed in the CsA-treated, but not 
in the placebo-treated, patients [18,24]. 
Selection of Gro PCR Probes To detect gro transcripts, PCR 
pri~ers were sele.cted based on sequen.ces unique to each gro gene as 
prevIOusly descnbed [9]. The locatIOns, lengths, and predicted 
products of these primers are shown in Fig lA. The identity of the 
products derived was confirmed by digestion with the restriction 
enzymes Asp700 and Mael followed by blot hybridization to a 
mixed gro probe (Fig IB). 
Northern Blot Analysis of Gro Expression in Psoriasis Les-
ions Because of the high homology between the gro isoforms 
and the similarity in the lengths of the cognate transcripts [9]. We 
were unable to determine the pattern of isoform expression from 
Northern analysis, even using 30-mer oligonucleotide probes de-
signed to be isoform specific (data not shown). Nevertheless, it was 
still possible to measure the total gro mRNA levels by this tech-
nique. Using either gro-a (Fig 2) or gro-y (not shown) as probes, 
gro mRNA levels were markedly increased in keratome biopsy 
specimens from psoriatic lesions; however, the level was variable 
from patient to patient (Fig 2). In contrast, no hybridization could 
be observed to the same amount of RNA derived from normal skin 
using any of the gro probes (data not shown). The same blots were 
previously hybridized against an IL-8 probe [24] , and these results 
are reproduced for comparison in Fig 2. The patterns ofIL-8 and gro 
hybridization were very similar (Fig 2). The results shown in Fig 2, 
along with those obtained from an additional ten CsA-treated and 
four vehicle-treated patients, were quantitated by densitometry and 
phosphorimager and normalized to the control gene, cyclophilin. 
This analysis revealed a highly significant positive correlation be-
tween pretreatment IL-8 and gro mRNA levels (r = 0.61, P < 
0.0009, n = 26, Fig 3). 
VOL. 101 ;' NO. 6 DECEMBER 1993 
A 
Asp 700 
H-merl J. 
GR~a [1======jillllllllff~EIIIIIIII~5~no===========~ 
f:l2O-mer 
Mae I 
21-merl J. GR~~[I=========1.~"II·Eijil""~~~~3~Vr:~~~JI 
~21-mer 
Mae I 
17-mer' J. GR~rl -----I ... ~n~I .. ~aa~~~~~.-------~ 
B Ci 
r----1 
MW (bp) 
861 -
738-
615 -
492-
369-
246-
123 -
~ 
+ 
Asp 
700 
f3 
r----1 
~ 
+ 
Mae 
I 
fJ2~mer 
lOOn! 
I-----l 
"I 
r----1 
- f3 (743 bp) 
- Ci (580 bp) 
""I (545 bp) 
~ 
+ 
Mae 
I 
Figure 1. Discrimination of gro isoforms by SQRT-PCR. (A) Locations of 
primers and diagnostic restriction sites. Bar, entire length of gro-a: -p, and -)' 
transcripts. The locations, lengths offorward and reverse PCR primers, and 
predicted peR products arc shown. Locations of diagnostic cleavage sites for 
Asp700 and MaeI restriction enzymes are shown by arrows. (B) Confirma-
tion of peR product identity by restriction enzyme digestion. RT-PCR 
products aITlplified from lesional psoriatic RNA under non-quantitative 
conditions were digested with the indicated restriction enzymes, separated 
on a 1.5% agarose gel, blotted to nylon, and hybridized against a mixture of 
geo-a, -P, and -J' probes. Loadings of undigested and digested products are 
nor proportional; the IIIldigested la/les contain approximately five times. as 
much peR product as the digested lalles. Failltlower ballds in the lalles contam-
ing undigested PCR products reflect nonspecific priming events. Mobilities 
of 123 ladder size markers are indicated to the lift. 
A marked reduction in gro mRNA levels was apparent after 
1 week of CsA treatment (Fig 2). Quantitation of the blots revealed 
a 79.3% reduction in mean gro mRNA levels in response to CsA 
(p = 0.01. n = 22). w hich ~as very similar in 111agn~tude to that 
previously reported for IL-8 111 the same group of patIents [24]. In 
contrast. only a small reduction in CRABP-I1 expression was seen 
in the same group of treated patients, as reported previously [24] 
(Fig 4 ) . 
Profile of Gro Isoform Over expression In Vivo Because 
Northern blotting was unable to distinguish between the gro iso-
forms, semiquantitative PCR was used to determine the pattern of 
gro isoform expressi?n in psoriatic lesions. In prelimin~ry experi-
ments. it -was determmed that the amounts ofPCR-amrllfied gro-(l' 
and IL-8 products were proportional to the amount 0 input RNA 
when 23 cycles of PCR amplification were used (data not shown). 
GRO EXPRESSION IN PSORIASIS 769 
5 5 3 3 3 3 5 5 
..£.2...£ 2. CsA, mg/kg 
0101020101010101 o 1 0 1 0 1 0 1 week 
~ IL-8 
~GRO 
~CYCLO 
~ LlPO II 
BLOT # 1 BLOT # 2 
Figure 2. N.orthern blot analysis of CsA effects on gro and IL-8 mRNA 
levels 111 psonatlc skill. Re-hybridizations of fWO different blots are shown. 
The results shown for IL-8, cyclophilin, and lipocorrin II have been pub-
hshe~ prevJOu~ly [24] and are lIlcluded here only for purposes of comparison. 
Mobilities of rI.bosomaI RNAs are indicated to the lift, and the hybridization 
prob~ used IS lIldlcated to .rhe right (GRO denotes use of a gro-a probe; 
Identical results were obtallled usmg gro-J' or a mixture of all three gro 
probes; data not shown). Cyclo. cyclophilin; lipo II, lipocortin II. 
Therefore, 23 cycles of amplification were used in all experiments 
show.n. U~der these conditions, the fJ-globin control showed linear 
amplificatIOn over a range of 0.2- 5 attomoles input RNA (data not 
shown). In Rr:-rA extracted from biopsies of normal skin, IL-8 and 
all three gro ISO forms were undetectable under these conditions 
whereas 0.2 attomole of fJ-globin control mRNA was readily de~ 
tectable (data not shown) . In psoriatic lesions. all three forms of gro 
we~e e~pressed. J:Iowever, all patients consistently expressed gro-(l' 
at s.lgmficantly 11lgher levels than gro-fJ or gro-y (Fig 5). By com-
p~nson With spe~lfic hybridization signals at the highest non-satur-
atmg le~els o~ mput RNA (7.5 ng loaded, corresponding to 40 
ng/reactlOn) , It .can be estimated that in untreated psoriatic lesions 
gro-(l' mRNA IS present at 6.5 ± 1.2 times the level of gro-fJ 
(mean ± SEM, n = 5, 95% confidence interval = 3.1-9.9, P = 
0.01), and 24.7 ± 6.9 times the level of gro-y (95% confidence 
interval = 5.4 - 43.9, P = 0.03). 
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Figure 3. Correlation of gro and IL-8 mRNA levels in lesional psoriatic 
keratome biopsies. Each poitlt, different individual, biopsied at week 0 of the 
CsA study. The best fit to the data after linear regression analysis is indicated 
by the litle. 
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Figure 4. Quantitation of CsA effects on gro mR~A levels in psoriatic 
skin. Opell bars, week 0; closed bars, week 1. The reductIOn of gro tr~nscnpts at 
week 1 was significant at the p < 0.02 level by a two-sided paIred t test. 
Results of a previously reported [24] analysis of the same group of patients for 
IL-8 and CRABP-II mRNA levels arc indicated by an asterisk and are in-
cluded here for comparison only. Error bars, SEM (n = 22). 
Effects of CsA Treatment on Gro Isoform Expression 
Northern blotting and SQRT-PCR were in excellent agreement in 
comparison of the relative levels of gro, IL-8, and CRABP-II 
mRNAs before and after 1 week of CsA therapy. All three forms of 
gro were reduced by the same percentage of their pretreatment 
values (Fig 6). 
Gro Isoform Expression in Cytokine-Stimulated Cultured 
Keratinocytes Subconfluent keratinocytes in modified MCDB 
153 medium (KGM) expressed little if any gro mRNA, as deter-
mined by Northern blotting. However, gro transcripts were mark-
edly induced by treatment with 20 ng/ml IL-la or by 100 U/ml 
IFN-y in combination with 20 ng/ml TNF-a (Fig 7 A). Two bands 
of about 1.0 (closed arrow) and 1.2 kb (open arrow) were detectable, 
and IL-la treatment consistently resulted in more expression of the 
1.2-kb band. As expected, all three PCR-generated gro probes de-
tected similar band patterns. Therefore, the presence of all three gro 
isoforms in cytokine-stimulated cultured keratinocytes was con-
firmed by reverse transcription (RT)-PCR (Fig 7B). As previously 
reported for IL-8 [24] , overnight pretreatment with CsA (0.1 -1 0 
ttg/ml) had no detectable inhibitory effect on cytokine-induced gro 
l~k::::: J2:::::~ [~ i 
a:- 1 5 75 37.5 1.5 7.5 37.5 a: . . m 
I ~k; k:==:; t~ i 
U 1.5 7.5 37.5 1.5 7.5 37.5 
INPUT mRNA (ng) 
Figure 5. Semiquantitative PCR analysis of relative expression of different 
gro isoforms in psoriatic lesions. X and Y axis values refer to th~ amounts of 
input material ana lyzed on the gel (15 III out of80 III total reactIOn volume). 
Y axis legend refers to net CPM in the band of expected size detected by the 
phosphorimager. Note different Y axis scales for each patient. Four offive 
patients analyzed are shown; the results from the fifth patient were Similar. 
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Figure 6. Agreement between PCR and Northern blotting. The same four 
patients were analyzed for IL-8 and gro mRNA expression before and after 
CsA treatment. Solid bars, quantitative Northern blotting; opell bars, SQRT-
PCR. Transcript levels analyzed by the two methods are given below the 
figure. Error bars, SEM (n = 4). The gro probe used for Northern blotting 
was a mixture of gro-a, -Po and -y PCR products as described in Materials and 
Methods. 
expression in cultured keratinocytes. In fact, a slight stimulatory 
effect was noted (Fig 7 A). 
DISCUSSION 
Gro was initially identified in 1987 on the basis of overexpression 
in tumorigenic, relative to nontumorigenic, Chinese hamster fi-
broblast cell lines [7]. Shortly thereafter, a factor with autocrine 
growth-stimulatory activity for human melanoma cells was identi-
fied and termed MGSA [8]. Shortly thereafter, it became clear that 
these factors were closely related or identical to a neutrophil-acti-
vating protein produced by monocytes [4- 6] and IL-l-stimulated 
dermal fibroblasts [39]. Recently, a search for full-length gro cDNA 
clones led to the realization that MGSA/gro activity is encoded by 
three tandemly duplicated genes that are 85 - 90% homologous at 
the protein level and are located within the intercrine-a or C-X-C 
gene cluster of human chromosomal band 4q12- 21 [9]. Because of 
the growth regulatory, chemotactic, and activating activities of gro, 
it was of interest to investigate gro gene expression in psoriasis, a 
disease characterized by prominent focal infiltration by neutrophils 
[32], as well as marked hyperproliferation of keratinocytes [33] and 
bone marrow-derived cells [34] . 
The expression of MGSA/gro in the skin was first reported by 
Richmond and Thomas in 1988 [35] . More recently, Schroder and 
co-workers have reported the presence of one or more gro-related 
peptides in psoriatic scale in greatly increased amounts relative to 
normal heel callus [36] . As shown in Fig 2, we have confinned the 
marked overexpression of gro transcripts in psoriatic lesions b 
Northern blotting. In fact, it was not possible to calculate a -fold 
overexpression of gro transcripts, as their expression was undetect-
able in keratome biopsies of normal human skin. Although infiltrat-
ing inflammatoty /immune cells may be expressing gro transcrip ts, 
these cells are too few in number for their transcripts to be readily 
detectable by the Northern blotting technique. Thus, transcripts 
encoding the T-cell-derived cytokines IL-2 and IFN-g are unde-
tectable in psoriatic lesions by Northern blotting, although they can 
be detected by reverse transcription and PCR (unpublished data). 
Therefore, these results strongly suggest that gro is actually being 
synthesized by epidermal keratinocytes in psoriatic lesions, and is 
not deposited in the epidermis by the circulation or infiltrating 
inflammatory cells. Further in situ hybridization experiments will 
be required to definitively identify the keratinocyte as the primary 
source of gro expression in psoriatic lesions. 
Overexpression of gro in psoriasis lesions was highly variable 
from patient to patient (Fig 2). In a recent study, we found that 
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Figure 7_ E xpression of gro transc ri pts in cultured adult keratinocytes. (A) 
Northern blo t analysis. Normal adult human keratinocytes grown in KGM 
(- 60% confluent) were pretreated overn ight (1 8 h) w.ith or without CsA at 
[he indicate d concentratIOns (0 , 1, 10 mg/ml) , then stimulated for 4 h With 
[he ind ica te d cytokines (100 U/ m! IFN-y plus 20 ng/ml TNF-a, or 20 
ng/ml IL-la). T otal RNA was isolated and 40 Jig RNA was loaded per lalle. 
Blots were h ybridized with the PC R product probes indicated below the 
panels. O pen and closed arrows, 1.2- and 1.0-kb bands discussed in the text. 
APrroxirnate mobilities of 18S and 28S ribosomal RNAs are given to the left· 
(B Express ion of gro isoforms in cytokine-stimulated cultured kera tlno-
cytes . Tota l RNA was extracted, reverse transcribed, and amplified by PCR. 
peR product (15 Ji l) was blotted and hybridized aga inst a mixture of gro-a, 
_p, and -y probes as described in Materials alld Metlrods. T he bracket labeled by 
[he asterisk t o the left of the figure I11dlcates nonspecific products of PCR 
2mplifi.cat ion. 
!I--IP a nd IL-8 were overexp ressed in ps.oriatic l es ion~ in a very 
similar fas hion (24] . On the baSIS of the ul11form and rap id normal!-
zation o f cytokine exp ress ion in response to CsA treatment, w e 
hypothe size d that p~oria tic keratino.cytes a.re overexpressing IL-8, 
and p ossibly IL-lp, 111 res~onse to stimulatIOn by act1~ated T cells. 
In this s tudy , the expreSSIOn o f g ro and IL-8 transcrIpts was a lso 
highly correlated (Fig 3), and gro overexpl:ession was mar~edly 
inhibi t e d b y C sA prio r to detectable chl11callmprovement (FIg 4). 
Taken t o gether, these results stro n gly sugges t that gro expressio n in 
kerarinocytes is regu lated by the same T -cell - dependent stimuli 
that regula t e IL-8. In view of the know n abili ty of IL-1 and IFN-y 
plus TNF-a to stimulate IL-8 express ion in keratinocytes (22,23], 
increased expression of th ese cytokines by T cells o r by other cells 
under the ir direction cou ld be the trigger for overexpression o f g ro 
by psoria tic lesional kera tinocytes. C onsistent with this hypothesis, 
both IL-l a and the combination of IFN-y p lus TNF-a w ere capa-
ble of s timulating gro gene expression in keratinocytes (Fig 7) . 
Alternative ly, this stimulus could be provided by direct contact w ith 
infil trating T cells them selves, as suggested by Stoof et al (37]. The 
fac r that CsA pretreatment h ad no inhibitory effect on gro expres-
sion in cytokine-stimulated cultured kerarinocytes (Fig 7) stro ngly 
suggest s tha t C sA does no t exert its antipsoriatic effects directly on 
the keratinocyte. As discussed in the accompanying paper [24], the 
slighr stimulatory effect of CsA o n cytokine-stimul ated gro expres-
sion h as a lso been observed fo r several o ther kera tl110cyte cyto kine 
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and growth fac tor responses in culture , and may in fact reflect a 
potentiation, rarher than an inhibition, ofkeratinocyte signal rrans-
duction in response to cytokine treatment. 
Given the recent d iscovery of three different gro genes [9], these 
resul ts pron~pted us to ask which form(s) of gro are overexpressed in 
pson atlc leSIOn s. Because we were unable to distinguish gro isoform 
transcript~ by Northern blot analysis, we tIlrned to semiquantitative 
PCR to dlSt1l1gUlSh between these transcripts, and to determine the 
effects of CsA on the expression of each isoform. In five patients 
known to overexpress gro and IL-8 mRNA by Northern blotting, 
this analysis demonstrated thar gro-a was by far the most abundant 
transcript observed. Consistent wirh these observations, Schroder 
and colleagues have independently demonstrated the selective over-
abundan ce of gro-a protein in psoriatic scale by amino acid se-
quencing (36] (J. M. Schroder, personal communication). The fact 
that all three isoforms were reduced to the same extent after CsA 
treatment (Fig 6) ind icates that all three isoforms may be responsive 
to the proposed T -ccll - dependent stimu lus discussed above. The 
mech anism(s) responsible fo r the selective overexpression of gro-a 
111 pson atlc leSIOns ~emal11 unknown. All three isoforms appear to be 
overexpressed to sll11l lar extents in cyrokine-stimu lated cultllred 
keratinocytes(Fig 7B); I:owever, more careful analysis is required to 
docume.nt thl~ observation w ith certainty. By analogy with IL-8 
(~8] , It IS pOSSIble th at gro-a is preferentially expressed by high ly 
di fferen tiated kera t l110cytes of the upper stratum spinosum. 
Taken together, our i ll Il illO and ill lIitro data suggest thar CsA acts 
to reduce the production by keratinocytes of multiple proinflamma-
tory cytokines belongll1g to the intercrine-a family. This mecha-
I1lsm. of action appears to involve inhibition of aT-cell - dependent 
p roXimal stimulus, but not t he abi lity ofkeratinocytes to respond to 
these Signals. Moreover, SQRT-PCR appears to be a sensitive and 
relIab le measure of mRNA levels in human skin, of special value 
w hen rhe amou nt of sample is limited, when the targe t transcript 
levels are low, or w h en h ighly sim ilar transcripts must be d istin-
guished . 
We Ivish to thallk Dr. Gopa Majllllldar, Departlllellt oJDerlllatology, UllillersityoJ 
Mich igallJor helpJul adllice. The expert statistical assistallceoJTedHallliitoll, M.S. , 
OIld tire skilled teclrllical assistallce oj Dialle BOlllall alld Qiollg Yallg are gratiflllly 
ackllowledged. 
Th is work was sllpported by USPHS award R29 AR40016 UTE, GJF), by tire 
Departlllellt 0JVetera ll s Affairs UTE) , alld tire Babcock Melllorial Tmst. PortiollS 
oJthis stlldy were colldllCled 011 tire Gelleral Clillical Researelr Cell ter at the Ulliller-
sity oj Miclr igatl, jtlllded by a grallt (MOt RR0042) frOIll tire Natiollal Gell ter Jor 
Research Resources, Nat iolla l Illstitlltes oj Health. 
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